TAOX NASDAQ
TAOâ¯Synergies Inc.
1W: -24.7%
1M: -9.6%
3M: +21.7%
YTD: +2.5%
$4.54
-0.25 (-5.22%)
Pre-Market: $4.67 (+0.13, +2.97%)
Weekly Expected Move ±12.6%
$4
$5
$5
$6
$7
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Smart Money Score
No convergence signal
Key Statistics
Market Cap$14.9M
52W Range2.12-11.98
Volume115,231
Avg Volume187,757
Beta1.54
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEOJoshua N. Silverman
Employees4
SectorHealthcare
IndustryBiotechnology
IPO Date2025-07-02
Websitesynaptogen.com
1185 Avenue of the Americas, 3rdâ¯Floor
New York 10036
US
New York 10036
US
About TAOâ¯Synergies Inc.
Clinical-stage biopharmaceutical company developing a bryostatinâ1 platform for Alzheimerâs and other neurodegenerative/cognitive diseases. Also pivoting to a digital-asset treasury strategy focused on acquiring and staking TAO cryptocurrency.
Latest News
US Stocks Mixed; Dow Falls Over 100 Points
12 Information Technology Stocks Moving In Friday's Pre-Market Session
12 Information Technology Stocks Moving In Wednesday's Pre-Market Session
12 Information Technology Stocks Moving In Tuesday's Intraday Session
12 Information Technology Stocks Moving In Friday's Intraday Session
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Silverman Joshua | A-Award | 200,000 | $4.80 | 2026-05-18 |
| Bernstein Bruce | A-Award | 55,000 | $4.80 | 2026-05-18 |
| Singer William S. | A-Award | 35,000 | $4.80 | 2026-05-18 |
| WEINSTEIN ROBERT | A-Award | 30,000 | $4.80 | 2026-05-18 |
| Ephron Robert | A-Award | 10,000 | $4.80 | 2026-05-18 |